Get a demo
Products
Solutions
Company
News
Careers
Get a demo
Products
Solutions
Company
News
Careers
Get a demo
Back to news
September 22, 2025
The End of One-Way Streets: How AI Is Transforming Pharma Email and SMS
By
Location
If you build it, tariffs won’t come: Pharma’s billion-dollar ultimatum
Previous post
Next post
How AI Will Change Pharmaceutical Email and SMS Forever
Previous post
Next post
Ostro Debuts a New Digital Experience for Life Sciences Enabling Smarter, More Seamless AI-Powered Provider & Patient Engagement
Previous post
Next post
The End of One-Way Streets: How AI Is Transforming Pharma Email and SMS
Previous post
Next post
How AI Powers the Future of Omnichannel Engagement
Previous post
Next post
FDA's Undisclosed DTC Ad Letters Target Specific Drug Ads, Websites, Patient Brochures
Previous post
Next post
From Awareness to Action: 36x More Rep Conversations with Personalized HCP Engagement
Previous post
Next post
How AI is powering a new email tool to drive HCP engagement
Previous post
Next post
Ostro’s Airmark Revolutionizes Pharma Email Marketing with AI
Previous post
Next post
Ostro Debuts Airmark to Turn Static Pharma Emails into Real-Time, Compliant AI Conversations
Previous post
Next post
Sharing personal health data for monetary gain? Healthline’s California Conundrum
Previous post
Next post
Ostro Launches AI Tool For Clinicians To Engage With Pharma Companies
Previous post
Next post
Ostro Launches Airmark to Transform Static Pharma Marketing Emails into Compliant, Conversational AI
Previous post
Next post
AI anxiety has sent markets into a tizzy, but experts say the jitters will only ‘punish those chasing the froth’
Previous post
Next post
Pharma looks to appease Trumpwith DTC sales, but sidesteps MFNpricing
Previous post
Next post
The Flo Health – Meta data privacy case: What medical marketers can learn
Previous post
Next post
Navigating pharma's AI frontier: crafting customer journey orchestration for impact
Previous post
Next post
What do digital health leaders think of Trump’s new AI Action Plan?
Previous post
Next post
Industry looking to adapt under shadow of US Rx tariffs
Previous post
Next post
2025 Fierce Pharma Marketing Awards Finalists
Previous post
Next post
AI in Pharma: Why regulatory rigor is a catalyst, not a constraint
Previous post
Next post
Big Pharma borrows a page from pro athletes' marketing playbook
Previous post
Next post
A bright spot for biotech in Trump’s megabill
Previous post
Next post
Beyond food: GLP-1 drugs disrupt everything from casino apps, to retail, and airlines
Previous post
Next post
Four keys to successfully launching AI in life sciences
Previous post
Next post
Fierce Pharma Week
Previous post
Next post
Are there any healthcare wins hidden inside the One Big Beautiful Bill Act? Yes, a few…
Previous post
Next post
Trump’s executive order to lower Rx drug prices
Previous post
Next post
Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Previous post
Next post
FDA's Elsa AI is here, and the industry has questions
Previous post
Next post
Why FDA's Elsa AI tool was inevitable (and just the beginning)
Previous post
Next post
FDA's new 'Elsa' AI set to expedite clinical protocol reviews
Previous post
Next post
White Paper: Transforming Life Sciences with Conversational AI
Previous post
Next post
Havas deepens AI leadership through strategic partnership with Ostro
Previous post
Next post
Future Pharma Summit
Previous post
Next post
Ostro Files Provisional Patent for Machine Learning-Based Search Optimization Technology
Previous post
Next post
Momentum ReImagine Pharma
Previous post
Next post
How pharma-backed websites are easing doctors’ search woes through AI
Previous post
Next post
Inside Takeda’s Plasma-Derived Therapy Ecosystem
Previous post
Next post
Ostro Partners with Desmoid Tumor Research Foundation
Previous post
Next post
Why Fine Tuning is Not Fine for Pharma Marketing
Previous post
Next post
Navigating the New ABPI Code: What Pharma Marketers Need to Know
Previous post
Next post
How Gilead Is Driving Global Health Equity And Innovation
Previous post
Next post
Ostro named Top 100 Healthcare Technology Companies of 2024
Previous post
Next post
Time on Website, or Wasting Time – What Pharma Brands Should Keep in Mind When Measuring Digital Engagement
Previous post
Next post
Ostro Helps Make Medicine Make Sense: Q/A with Ostro Co-Founder & President Ahmed Elsayyad
Previous post
Next post
‘More Siloed Than Ever’: Pharma’s Deep Digital Disconnect
Previous post
Next post
Bringing Best-in-Class Consumer Experience to Life Sciences
Previous post
Next post
A Consumerized Diagnostic: Looking Back And Ahead On A Decade Of Cologuard
Previous post
Next post
Staying Ahead of Medical Misinformation
Previous post
Next post
White Paper: How the Healthcare System Fails its Providers
Previous post
Next post
How This $4.3B Pharma Company Is Helping Underserved Patients in Neuro
Previous post
Next post
Three Ways AI is Revolutionizing Life Sciences Marketing
Previous post
Next post
White Paper: AI’s Rapid Evolution in Life Sciences Marketing and Sales
Previous post
Next post
Dermavant taps AI for ‘white-glove’ website service for Vtama psoriasis medicine
Previous post
Next post
How a Strategic Focus Defined Vertex's Mission
Previous post
Next post
Unlocking Brand Conversion: A Data-Driven Exploration
Previous post
Next post
Guide: Transforming Brand Interaction Through Empathy and Technology
Previous post
Next post
White Paper: Bridging the Information Gap
Previous post
Next post
Serendipity And Science: Forging Billion-Dollar Oncology Breakthroughs
Previous post
Next post
Pharma's Two Biggest Mistakes
Previous post
Next post
How this CEO Built a Top 50 Pharma Company Focusing on Culture Day 1
Previous post
Next post
A Decade of Innovation: How this CEO Transformed a Global Pharma Giant
Previous post
Next post
How This CEO Consumerized Cancer Diagnostics Into A $13B Enterprise
Previous post
Next post
40 Under 40: Dr. Chase Feiger, Ostro
Previous post
Next post
How this CEO Built A Top 50 Pharma Company Focusing On Culture Day 1
Previous post
Next post
MM+M announces 2024’s 40 Under 40 honorees
Previous post
Next post
Bringing Generative AI to Healthcare
Previous post
Next post
Brand.com 2.0: A Call to Action for Life Sciences Brands
Previous post
Next post
Elevating health literacy: A win-win for consumers and life sciences companies
Previous post
Next post
This Time It’s Personal—The Key to Improving HCP Engagements
Previous post
Next post
CooperSurgical® and Ostro Named Best Patient Education Solution in the 7th Annual MedTech Breakthrough Awards
Previous post
Next post
3 ways to make sure TV and print ads are driving next-best actions
Previous post
Next post
The key elements to a successful and sustainable patient engagement strategy
Previous post
Next post
The evolving patient journey
Previous post
Next post
Ostro grows annual revenue by over 250%, closes Series B funding, celebrates co-founder
Previous post
Next post
CooperSurgical® partners with Ostro to educate consumers about Paragard® (intrauterine copper contraceptive)
Previous post
Next post
InnovationRx: Under 30 innovators, avoiding Covid brain fog and facing a tripledemic
Previous post
Next post
Axios exclusive: RxDefine, now Ostro, raises $45M for health engagement
Previous post
Next post
Ahmed Elsayyad named 30 under 30 by Forbes
Previous post
Next post
RxDefine is now Ostro
Previous post
Next post
3 HCP hurdles and how marketing can overcome them
Previous post
Next post
4 reasons 1:1 engagement can help you stay ahead of the competition
Previous post
Next post
5 questions to ask about whether telehealth is right for your life sciences brand
Previous post
Next post
5 things life sciences brands should look for when choosing a telehealth provider
Previous post
Next post
5 ways life sciences marketing is missing the mark
Previous post
Next post
Schedule a demo
%20(2).png){kind=logo}
.svg)